Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

PURPOSE: Patients treated with warfarin must adhere to frequent monitoring, dietary restrictions, and complicated dose adjustments. Apixaban, a direct factor Xa inhibitor, is an alternative to warfarin that may reduce patient burdens associated with warfarin therapy. However, there is limited eviden...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Patient Prefer Adherence
Main Authors: Koretsune, Yukihiro, Ikeda, Takanori, Kozuma, Ken, Hirano, Teruyuki, Yasaka, Masahiro, Kida, Makoto, Chachin, Motohiko, Imura, Miki
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735985/
https://ncbi.nlm.nih.gov/pubmed/29290682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S152579
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki